Roy D. Baynes Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 1 day, 18 hours ago
Roy D. Baynes has an estimated net worth of at least $11.8 million*, as of April 29, 2026. They own 18,512 shares of NTRA stock. They have sold 118,760 shares of NTRA stock since 2021, for an estimated $8.2 million.
Roy D. Baynes $NTRA SEC Form 4 Insider Trading
Roy D. Baynes has filed a total of 14 insider trades in $NTRA since 2021. Their most recent trade was a sale of 1,884 shares, made on Nov 20, 2025. Their largest trade was a sale of 16,404 shares, made on Nov 15, 2024. We estimate that they now own 18,512 shares of $NTRA, worth an estimated $3.6 million.
Insider Trading at $NTRA
There have been a total of 1178 insider trades reported at $NTRA since 2021, with 375,220 shares purchased and 4.8 million shares sold. The most active insider traders in $NTRA stock have been Steven Leonard Chapman, Michael Burkes Brophy, and Daniel Rabinowitz. The most recent trade was a sale of 1,222 shares reported by Michael Burkes Brophy (CHIEF FINANCIAL OFFICER), made on Apr 27, 2026.
History of Insider Stock Trades by Roy D. Baynes
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
TVTX
|
Sale | 26,000 | Apr 14, 2026 | April 16, 2026, 4:05 p.m. |
|
TVTX
|
Sale | 6,750 | Apr 14, 2026 | April 16, 2026, 4:05 p.m. |
|
TVTX
|
Sale | 10,000 | Apr 06, 2026 | April 7, 2026, 6:17 p.m. |
NTRA
|
Sale | 1,884 | Nov 20, 2025 | Nov. 21, 2025, 9:05 p.m. |
|
NTRA
|
Sale | 1,727 | Nov 19, 2025 | Nov. 21, 2025, 9:05 p.m. |
|
NTRA
|
Sale | 2,135 | Nov 19, 2025 | Nov. 21, 2025, 9:05 p.m. |
|
NTRA
|
Sale | 1,184 | Nov 20, 2025 | Nov. 21, 2025, 9:05 p.m. |
|
NTRA
|
Sale | 900 | Nov 20, 2025 | Nov. 21, 2025, 9:05 p.m. |
|
NTRA
|
Sale | 1,800 | Nov 20, 2025 | Nov. 21, 2025, 9:05 p.m. |
|
NTRA
|
Sale | 1,900 | Nov 20, 2025 | Nov. 21, 2025, 9:05 p.m. |
|
NTRA
|
Sale | 1,250 | Nov 19, 2025 | Nov. 21, 2025, 9:05 p.m. |
|
TVTX
|
Sale | 10,000 | Feb 06, 2025 | Feb. 10, 2025, 7:04 p.m. |
|
TVTX
|
Sale | 16,000 | Jan 23, 2025 | Jan. 23, 2025, 9:36 p.m. |
|
NTRA
|
Sale | 16,404 | Nov 15, 2024 | Nov. 15, 2024, 10:50 p.m. |
|
NTRA
|
Sale | 1,770 | Nov 15, 2024 | Nov. 15, 2024, 10:50 p.m. |
|
NTRA
|
Sale | 9,467 | Nov 15, 2024 | Nov. 15, 2024, 10:50 p.m. |
|
NTRA
|
Sale | 2,106 | Nov 15, 2024 | Nov. 15, 2024, 10:50 p.m. |
|
NTRA
|
Sale | 1,983 | Nov 15, 2024 | Nov. 15, 2024, 10:50 p.m. |
|
NTRA
|
Sale | 5,500 | Nov 15, 2024 | Nov. 15, 2024, 10:50 p.m. |
$NTRA Executives and Stock Owners with Insider Trades
-
Steven Leonard Chapman, CEO AND PRESIDENT
-
Michael Burkes Brophy, CHIEF FINANCIAL OFFICER
-
Daniel Rabinowitz, SEC. AND CHIEF LEGAL OFFICER
-
Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS
-
Matthew Rabinowitz, EXECUTIVE CHAIRMAN
-
John Fesko, PRESIDENT, CHIEF BUS. OFFICER
-
Robert Alan Schueren, CHIEF OPERATING OFFICER
-
Daniel Rabinowitz, CHIEF LEGAL OFFICER
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.